Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|
Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|---|---|---|---|---|---|---|---|
Q3 2024 | 42 | $1.84B | +$195M | -$21.1M | +$174M | ACLX, TEM, VRNA, RYTM, SVRA | 13F-HR | 11/14/2024, 05:19 PM |
Q2 2024 | 41 | $1.33B | +$186M | -$97.9M | +$88.1M | ACLX, TEM, RYTM, SVRA, COUR | 13F-HR | 8/14/2024, 04:34 PM |
Q1 2024 | 44 | $1.32B | +$36.9M | -$57.5M | -$20.6M | ACLX, RYTM, SVRA, KRRO, VRNA | 13F-HR | 5/15/2024, 04:44 PM |
Q4 2023 | 44 | $1.46B | +$9.23M | -$75.7M | -$66.5M | COUR, ACLX, RYTM, SVRA, VRNA | 13F-HR | 2/14/2024, 05:03 PM |
Q3 2023 | 46 | $1.24B | +$15.9M | -$56.5M | -$40.6M | COUR, ACLX, SVRA, VRNA, CRSP | 13F-HR | 11/14/2023, 01:06 PM |
Q2 2023 | 44 | $1.31B | +$63.8M | -$349M | -$285M | COUR, ACLX, VRNA, CRSP, SVRA | 13F-HR | 8/11/2023, 04:47 PM |
Q1 2023 | 53 | $1.45B | +$18.8M | -$202M | -$183M | COUR, ACLX, VRNA, MIRM, IONQ | 13F-HR | 5/15/2023, 01:36 PM |
Q4 2022 | 57 | $1.78B | +$27.1M | -$187M | -$160M | COUR, ACLX, VRNA, RYTM, BHG | 13F-HR | 2/10/2023, 02:20 PM |
Q3 2022 | 57 | $1.91B | +$84.1M | -$63.1M | +$21M | BHG, COUR, IONQ, ACLX, RYTM | 13F-HR | 11/14/2022, 05:12 PM |
Q2 2022 | 57 | $1.95B | +$61.4M | -$700M | -$639M | BHG, COUR, IONQ, ACLX, CRSP | 13F-HR | 8/15/2022, 01:28 PM |
Q1 2022 | 57 | $2.95B | +$104M | -$377M | -$273M | HOOD, BHG, IONQ, NET, BGRY | 13F-HR | 5/16/2022, 01:36 PM |
Q4 2021 | 58 | $4.95B | +$843M | -$530M | +$313M | HOOD, BHG, IONQ, COUR, NET | 13F-HR | 2/14/2022, 05:03 PM |
Q3 2021 | 63 | $8.02B | +$3.42B | -$332M | +$3.09B | HOOD, BHG, COUR, BGRY, ALLK | 13F-HR | 11/12/2021, 03:50 PM |
Q2 2021 | 63 | $7.63B | +$4.15B | -$559M | +$3.59B | BHG, COUR, NET, CRSP, DM | 13F-HR | 8/2/2021, 11:25 AM |
Q1 2021 | 58 | $4.43B | +$1.14B | -$216M | +$928M | COUR, DM, EAR, ALLK, NET | 13F-HR | 5/14/2021, 01:47 PM |
Q4 2020 | 57 | $3.79B | +$1.08B | -$244M | +$832M | DM, ALLK, EAR, CRSP, NET | 13F-HR | 2/16/2021, 11:15 AM |
Q3 2020 | 54 | $2.35B | +$337M | -$229M | +$109M | SPT, ALLK, ADAP, CRSP, OYST | 13F-HR | 11/6/2020, 02:31 PM |
Q2 2020 | 46 | $2.49B | +$114M | -$489M | -$375M | SPT, MRSN, OYST, ADAP, ALLK | 13F-HR | 8/5/2020, 04:31 PM |
Q1 2020 | 50 | $1.91B | +$226M | -$85.8M | +$141M | RARX, OYST, SPT, ALLK, NET | 13F-HR | 5/6/2020, 04:17 PM |
Q4 2019 | 47 | $2.11B | +$368M | -$12.1M | +$356M | RARX, ALLK, SPT, OYST, CRSP | 13F-HR | 1/24/2020, 10:48 AM |
Q3 2019 | 46 | $1.21B | +$121M | $0 | +$121M | ALLK, RARX, RYTM, CRSP, NET | 13F-HR | 10/11/2019, 03:19 PM |
Q2 2019 | 44 | $1.43B | +$127M | -$698M | -$572M | RARX, GLYC, RYTM, CRSP, ALLK | 13F-HR | 8/7/2019, 11:07 AM |
Q1 2019 | 45 | $1.91B | +$47M | -$856M | -$809M | ESTC, RARX, RYTM, GLYC, ALLK | 13F-HR | 5/8/2019, 03:18 PM |
Q4 2018 | 46 | $2.52B | +$521M | -$6K | +$521M | TSRO, ESTC, RYTM, ALLK, RARX | 13F-HR | 1/18/2019, 12:41 PM |
Q3 2018 | 44 | $2.29B | +$253M | -$8.75M | +$244M | TSRO, ADAP, SENS, RYTM, GLYC | 13F-HR | 11/13/2018, 03:31 PM |
Q2 2018 | 43 | $2.13B | +$92.6M | -$126M | -$33.6M | TSRO, ADAP, RYTM, GLYC, MRSN | 13F-HR | 8/9/2018, 03:48 PM |
Q1 2018 | 43 | $2.25B | +$94.3M | -$36M | +$58.4M | TSRO, CRSP, ADAP, GLYC, MRSN | 13F-HR | 5/10/2018, 01:45 PM |
Q4 2017 | 43 | $2.41B | +$215M | -$76.5M | +$138M | TSRO, GLYC, RYTM, MRSN, DERM | 13F-HR | 2/8/2018, 10:12 AM |
Q3 2017 | 44 | $2.86B | +$189M | -$91.9M | +$97.1M | TSRO, MRSN, EPZM, GLYC, SENS | 13F-HR | 11/3/2017, 11:33 AM |
Q2 2017 | 44 | $2.75B | +$205M | -$35.2M | +$170M | TSRO, MRSN, AKAOQ, DERM, GLYC | 13F-HR | 7/26/2017, 03:21 PM |
Q1 2017 | 38 | $2.88B | +$101M | -$79.4M | +$21.6M | TSRO, ARDX, AKAOQ, DERM, EPZM | 13F-HR | 5/10/2017, 04:23 PM |
Q4 2016 | 39 | $2.51B | +$149M | -$77.5M | +$71.1M | TSRO, ARDX, DERM, EPZM, SENS | 13F-HR | 2/9/2017, 01:14 PM |
Q3 2016 | 39 | $2.23B | +$51.2M | -$108M | -$56.4M | TSRO, ARDX, DERM, GRPN, SENS | 13F-HR | 11/10/2016, 10:53 AM |
Q2 2016 | 39 | $1.93B | +$44M | -$104M | -$60.2M | TSRO, GRPN, SENS, ARDX, DERM | 13F-HR | 8/4/2016, 05:40 PM |
Q1 2016 | 37 | $1.51B | +$300M | -$46.7M | +$253M | TSRO, GRPN, ARDX, ADAP, EPZM | 13F-HR | 5/11/2016, 05:25 PM |
Q4 2015 | 34 | $1.57B | +$71.1M | -$171M | -$100M | TSRO, ARDX, GRPN, DERM, OPWR | 13F-HR | 1/22/2016, 02:00 PM |
Q3 2015 | 35 | $1.52B | +$23.9M | -$77.1M | -$53.2M | TSRO, ARDX, GRPN, SUPN, CLVSQ | 13F-HR | 11/10/2015, 04:42 PM |
Q2 2015 | 34 | $1.91B | +$86.4M | -$546M | -$460M | TSRO, GRPN, ARDX, SUPN, EPZM | 13F-HR | 7/15/2015, 02:40 PM |
Q1 2015 | 36 | $2.21B | +$102M | -$176M | -$73.6M | TSRO, GRPN, CLVSQ, SUPN, HPTX | 13F-HR | 5/6/2015, 04:36 PM |
Q4 2014 | 35 | $2.06B | +$91.9M | -$205M | -$113M | TSRO, GRPN, OPWR, CLVSQ, RNA | 13F-HR | 1/26/2015, 12:02 PM |
Q3 2014 | 35 | $1.97B | +$228M | -$206M | +$21.4M | GRPN, TSRO, OPWR, EPZM, CVT | 13F-HR | 10/24/2014, 03:19 PM |
Q2 2014 | 31 | $2.13B | +$231M | -$13.1M | +$218M | GRPN, TSRO, EPZM, CVT, OPWR | 13F-HR | 7/30/2014, 06:32 PM |
Q1 2014 | 28 | $2.04B | +$206M | -$143M | +$63.5M | GRPN, TSRO, CVT, CLVSQ, EPZM | 13F-HR | 5/1/2014, 01:50 PM |
Q4 2013 | 29 | $2.07B | $0 | $0 | GRPN, TSRO, CVT, CLVSQ, EPZM | 13F-HR | 1/29/2014, 03:02 PM |